Global Cancer Immunotherapies Market 2016-2020 Size and Share Published in 2016-04-27 Available for US$ 2500 at Researchmoz.us Description Cancer immunotherapy works by enhancing the innate powers of the immune system. This has better chances of successfully fighting cancer for a long period. Also, immunotherapies have fewer side effects and can treat different types of cancer. Cancer immunotherapies make up nearly 50% of the cancer drugs market. Technavios analysts forecast the global cancer immunotherapies market to grow at a CAGR of 15.17% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global cancer immunotherapies market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of cancer immunotherapies used to treat cancer.

1. Title:
Global Cancer Immunotherapies Market to Grow at a CAGR of 15.17% by 2016-
2020, Market Organization and Principles Report
Short Summary
Global Cancer Immunotherapies Market 2016-2020 Size and Share Published in
2016-04-27 Available for US$ 2500 at Researchmoz.us
Description
Cancer immunotherapy works by enhancing the innate powers of the immune system.
This has better chances of successfully fighting cancer for a long period. Also,
immunotherapies have fewer side effects and can treat different types of cancer. Cancer
immunotherapies make up nearly 50% of the cancer drugs market.
Technavios analysts forecast the global cancer immunotherapies market to grow at a CAGR
of 15.17% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global cancer
immunotherapies market for 2016-2020. To calculate the market size, the report considers
the revenue generated from the sales of cancer immunotherapies used to treat cancer.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Get a Free Sample Copy of the Report: http://www.researchmoz.us/enquiry.php?
type=S&repid=715922
Technavio's report, Global Cancer Immunotherapies Market 2016-2020, has been prepared
based on an in-depth market analysis with inputs from industry experts. The report covers
the market landscape and its growth prospects over the coming years. The report also
includes a discussion of the key vendors operating in this market.
Key vendors
Amgen
Bristol-Myers Squibb
F. Hoffmann-La Roche
GlaxoSmithKline
Merck
Takeda Pharmaceuticals

2. Other prominent vendors
AbbVie
ADC Therapeutics
Agensys
Astellas
AstraZeneca
Bayer
Biogen
Biotech Pharmaceutical
Boehringer-Ingelheim
Celgene
Celldex Therapeutics
Chugai Pharmaceutical
CTI Biopharma
Daiichi Sankyo
Eli Lilly
Fortress Biotech
Genmab
Immunomedics
Intas Pharmaceuticals
Janssen Biotech
Kyowa Hakko Kirin
MedImmune
Morphotek
Neovii Biotech
Novartis
OncoMed Pharmaceuticals
Pfizer
Sanofi
Seattle Genetics
Spectrum Pharmaceuticals

3. TG Therapeutics
XBiotech
Market driver
Increase in demand for cancer monoclonal antibodies
For a full, detailed list, view our report
Market challenge
Patent expiry of top-selling drugs
For a full, detailed list, view our report
Market trend
Emergence of targeted and combination therapies
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analysts time when you purchase this market report.
Details are provided within the report.
Inquiry on this report: http://www.researchmoz.us/enquiry.php?
type=E&repid=715922
Table of Content
PART 01: Executive summary
Highlights

4. PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Overview of cancer immunotherapies
Epidemiology
Spending on cancer
Cost of cancer treatment
Reimbursement policies
Economic burden of cancer
Orphan drug designation and regulatory approvals
Browse All Oncology Market Research Reports at:
http://www.researchmoz.us/oncology-market-reports-108.html
About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research
reports worldwide. Our database is composed of current market studies from
over 100 featured publishers worldwide. Our market research databases
integrate statistics with analysis from global, regional, country and company
perspectives.
Contact Us:
ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us
http://www.researchmoz.us/